- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00793832
The Effect of Supervised Exercise on Physical Fitness and Energy Expenditure in Post Bariatric Surgery Patients
June 27, 2013 updated by: Abhimanyu Garg, University of Texas Southwestern Medical Center
The Effect of Supervised Cardiorespiratory Endurance Exercise Training on Physical Fitness and Energy Expenditure in Roun-en-Y Gastric Bypass and Gastric Banding Surgery Patients.
It is hypothesized that the patients in the EXDA group will be able to complete a structured exercise program at a level sufficient to accumulate at least 2000 kcal per week, and that the structured endurance activity will increase their physical fitness and total daily energy expenditure compared to the DA group.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- RYGB or GB surgery patients who are at least 12 weeks post surgery
- BMI of 40 or more
- age 18-70years
- sedentary lifestyle (energy expenditure of <35 kcal/kg/day measured by 7-day physical activity recall and no regular moderate physical activity exceeding 20 min/day within the previous 3 months)
- willingness to alter physical activity in accordance with the intervention programs
- English or Spanish speaking.
Exclusion Criteria:
- body weight > 180 kg
- cardiovascular disease
- pulmonary disease
- uncontrolled hypertension (resting DBP >100 or SBP >180 mm of Hg)
- visual or hearing impairment
- functional limitations (difficulty walking one-quarter mile or climbing 10 stairs)
- abnormal ECG on VO2max test ( >1 mm ST segment depression at < 5 METS or with symptoms such as atrial fibrillation, complex ventricular arrhythmias and 3rd degree atrioventricular block)
- known liver disease due to causes other than nonalcoholic steatohepatitis (liver transaminases > 2.5 times the upper limits of normal [SGPT>105 U/L, SGPT>120 U/L] or total bilirubin >1.5 mg/dL)
- hematocrit of less than 30%
- current alcohol abuse (>7 drinks or 210 g/wk for women and >14 drinks or 420 g/wk for men)
- recreational drug abuse
- current use of any drugs capable of inducing weight loss (e.g., orlistat, sibutramine, topiramate, etc.)
- major neuro-psychiatric illnesses impeding competence or compliance
- pregnancy and lactation
- chronic renal insufficiency (serum creatinine > 2 mg/dL)
- untreated thyroid disorders such as hypothyroidism and hyperthyroidism; and 17) bariatric surgical complications including anastomotic leak, wound complications, thrombotic disorders, intestinal obstruction, stomal complications, GI bleeding, recurrent severe abdominal pain, bilious vomiting.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
Supervised exercise.
|
supervised exercise
|
|
Active Comparator: 2
Diet Advice
|
Diet Advice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Exercise at a level sufficient to accumulate at least 2000kcal per week
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To compare body weight and composition, quality of life, fasting lipids and lipoproteins, and glycemic control between the two groups.
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Meena Shah, Ph.D, UT Southwestern Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2007
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
November 17, 2008
First Submitted That Met QC Criteria
November 18, 2008
First Posted (Estimate)
November 19, 2008
Study Record Updates
Last Update Posted (Estimate)
July 1, 2013
Last Update Submitted That Met QC Criteria
June 27, 2013
Last Verified
January 1, 2010
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- GCRC 837
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.